Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Children's Hospital Medical Center, Cincinnati
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Viatris Inc.
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of Mississippi Medical Center
University of Washington
OHSU Knight Cancer Institute
Beth Israel Deaconess Medical Center
Cellerant Therapeutics
Seoul St. Mary's Hospital
Children's Oncology Group
National Cancer Institute (NCI)
M.D. Anderson Cancer Center